PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Chickpea protein extract (CPE) significantly alleviated pancreatic β-cell injury caused by glucose toxicity and regulated serum cytokine levels in mouse models [PMID:42169263].
Chickpea hydrolysates and peptides exhibit hypocholesterolemic and cardiovascular disease (CVD) related bioactivity [PMID:37854353].
Consumption is associated with antioxidant, anti-inflammatory, antibacterial, antifungal, analgesic, and anticancer properties [PMID:33998131, PMID:32239331].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22916806 (2012) — Nutritional quality and health benefits of chickpea (Cicer arietinum L.): a review. · The British journal of nutrition
- 2.PMID: 21579861 (2010) — 1-Methyl-1,2,3,4-tetra-hydro-carbolin-2-ium-3-carboxyl-ate. · Acta crystallographica. Section E, Structure reports online
- 3.PMID: 37854353 (2023) — Nutritional composition, health benefits and bio-active compounds of chickpea (Cicer arietinum L.). · Frontiers in nutrition
- 4.PMID: 34712256 (2021) — Chickpea (Cicer arietinum L.) as a Source of Essential Fatty Acids - A Biofortification Approach. · Frontiers in plant science
- 5.PMID: 36430981 (2022) — Molecular Breeding and Drought Tolerance in Chickpea.